Skip to main content

Table 2 Prevalence and distribution of the NCEP-ATPIII criteria for metabolic syndrome of 190 patients

From: Metabolic syndrome increases operative mortality in patients with impaired left ventricular systolic function who undergo coronary artery bypass grafting: a retrospective observational study

  Metabolic Syndrome
  All Patients (n = 190) Absent (n = 103) Present (n = 87) P value
Obesity (BMI>25 kg/m2) 94 (49.5%) 22 (21.4%) 72 (82.8%) P<0.0001
Fasting glycemia ≥6.1 mmol/L or (and) Diabetes mellitus 102 (53.6%) 30 (29.1%) 72 (82.8%) P<0.0001
Triglycerides ≥1.69 mmol/L 57 (30%) 7 (6.8%) 50 (57.5%) P<0.0001
HDL cholesterol (<1.04 mmol/L in men and<1.29 mmol/L in women) 107 (56.3%) 39 (37.9%) 68 (78.2%) P<0.0001
Hypertension 108 (56.8%) 36 (35.0%) 72 (82.8%) P<0.0001
0 criteria 15 (7.9%) 15 (14.6%) 0
1 criteria 41 (21.6%) 41 (39.8%) 0
2 criteria 47 (24.7%) 47 (45.6%) 0
3 criteria 34 (17.9%) 0 34 (39.1%)
4 criteria 33 (17.4%) 0 33 (37.9%)
5 criteria 20(10.5%) 0 20 (23.0%)
  1. (BMI = body mass index, HDL = high-density lipoprotein, NCEP-ATP III=National Cholesterol Education Program Adult Treatment Panel III)
\